Growing concerns about clinical autonomy, competition, and patient access spurred states to increasingly enact legislation targeted at private equity investment in health care last year.

The new year will likely bring more deals subject to state review, tighter regulatory guardrails, and increased scrutiny of highly leveraged transactions and serial acquisitions consolidating multiple medical practices.

Read the full article on Bloomberg Law.